Tolga Tanguler

Companies

• Lexeo Therapeutics, Inc.Board member Nov 13, 2024 to now¹
• Alnylam PharmaceuticalsEVP, Chief Commercial Officer Mar 10, 2021 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Alnylam Pharmaceuticals ALNY34,297 shares³$8.0M at $231.83Mar 4, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 4, 2026Sold 208 shares at $325.67 of Alnylam Pharmaceuticals³
• Mar 4, 2026Sold 272 shares at $324.88 of Alnylam Pharmaceuticals³
• Mar 4, 2026Sold 767 shares at $323.84 of Alnylam Pharmaceuticals³
• Mar 4, 2026Sold 350 shares at $323.01 of Alnylam Pharmaceuticals³
• Mar 4, 2026Sold 289 shares at $321.82 of Alnylam Pharmaceuticals³
• Mar 4, 2026Sold 215 shares at $320.81 of Alnylam Pharmaceuticals³
• Mar 4, 2026Sold 102 shares at $320.01 of Alnylam Pharmaceuticals³
• Mar 4, 2026Sold 106 shares at $319.03 of Alnylam Pharmaceuticals³
• Mar 2, 2026Sold 37 shares at $332.64 of Alnylam Pharmaceuticals⁴
• Mar 2, 2026Sold 94 shares at $331.93 of Alnylam Pharmaceuticals⁴
• Mar 2, 2026Sold 81 shares at $330.85 of Alnylam Pharmaceuticals⁴
• Mar 2, 2026Sold 170 shares at $329.71 of Alnylam Pharmaceuticals⁴
• Mar 2, 2026Sold 100 shares at $328.71 of Alnylam Pharmaceuticals⁴
• Mar 2, 2026Sold 329 shares at $327.67 of Alnylam Pharmaceuticals⁴
• Mar 2, 2026Sold 392 shares at $326.81 of Alnylam Pharmaceuticals⁴
• Mar 2, 2026Sold 258 shares at $325.63 of Alnylam Pharmaceuticals⁴
• Mar 2, 2026Sold 90 shares at $324.65 of Alnylam Pharmaceuticals⁴
• Mar 2, 2026Sold 47 shares at $323.62 of Alnylam Pharmaceuticals⁴
• Mar 2, 2026Granted 4,769 shares of Alnylam Pharmaceuticals⁴
• Feb 27, 2026Exercised options 1,666 shares of Alnylam Pharmaceuticals⁵
• Feb 13, 2026Sold 1,959 shares at $310.08 of Alnylam Pharmaceuticals⁶
• Feb 12, 2026Granted 4,000 shares of Alnylam Pharmaceuticals⁶
• Jan 12, 2026Sold 15 shares at $377.82 of Alnylam Pharmaceuticals⁷
• Jan 12, 2026Sold 19 shares at $375.65 of Alnylam Pharmaceuticals⁷
• Jan 12, 2026Sold 14 shares at $374.44 of Alnylam Pharmaceuticals⁷